Endovascular treatment of femoral-popliteal disease

Seminars in Interventional Radiology

Volumn 26, Issue 4, 2009, Pages 303-314

  Geronemus, Adam Ryan ^a   Peña, Constantino S ^a  

^a BAPTIST CARDIAC AND VASCULAR INSTITUTE   (United States)

Author keywords

angioplasty; claudication; critical limb ischemia; stent; Superficial femoral artery

Indexed keywords

EID: 77958068372     PISSN: 07399529     EISSN: 10988963     Source Type: Journal    
DOI: 10.1055/s-0029-1242203     Document Type: Article

References (27)

1. Newman A B., Shemanski L, Manolio T A. et al, The Cardiovascular Health Study Group. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999 19 538-545
2. Hirsch A T., Haskal Z J., Hertzer N R. et al, American Association for Vascular Surgery Society for Vascular Surgery Society for Cardiovascular Angiography and Interventions Society for Vascular Medicine and Biology Society of Interventional Radiology ACC/AHA Task Force on Practice Guidelines American Association of Cardiovascular and Pulmonary Rehabilitation National Heart, Lung, and Blood Institute Society for Vascular Nursing TransAtlantic Inter-Society Consensus Vascular Disease Foundation. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006 47 1239-1312
3. Sharafuddin M J., Stolpen A H., Dixon B S., Andresen K J., Sun S, Lawton W J. Value of MR angiography before percutaneous transluminal renal artery angioplasty and stent placement. J Vasc Interv Radiol 2002 13 (9 Pt 1) 901-908
4. Norgren L, Hiatt W R., Dormandy J A., Nehler M R., Harris K A., Fowkes F G., TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007 45 (Suppl S) S5-S67 (Pubitemid 46151680)
5. Bradbury A, Gamgee S. Long term (5 year) results of BASIL Trial Show Open Surgery First to be Superior to Endovascular Treatment First for Critical Limb Ischemia. Presented at: Veith Symposium November 2008 New York
6. Adam D J., Beard J D., Cleveland T et al, BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005 366 1925-1934
7. Yilmaz S, Sindel T, Lüleci E. Ultrasound-guided retrograde popliteal artery catheterization: experience in 174 consecutive patients. J Endovasc Ther 2005 12 714-722
8. Spinosa D J., Harthun N L., Bissonette E A. et al. Subintimal arterial flossing with antegrade-retrograde intervention (SAFARI) for subintimal recanalization to treat chronic critical limb ischemia. J Vasc Interv Radiol 2005 16 37-44
9. Bolia A, Brennan J, Bell P R. Recanalisation of femoro-popliteal occlusions: improving success rate by subintimal recanalisation. Clin Radiol 1989 40 325
10. Nadal L L., Cynamon J, Lipsitz E C., Bolia A. Subintimal angioplasty for chronic arterial occlusions. Tech Vasc Interv Radiol 2004 7 16-22
11. Met R, Van Lienden K P., Koelemay M J., Bipat S, Legemate D A., Reekers J A. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review. Cardiovasc Intervent Radiol 2008 31 687-697
12. Clark T W., Groffsky J L., Soulen M C. Predictors of long-term patency after femoropopliteal angioplasty: results from the STAR registry. J Vasc Interv Radiol 2001 12 923-933
13. Krankenberg H, Schlüter M, Steinkamp H J. et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 2007 116 285-292
14. Duda S H., Pusich B, Richter G et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 2002 106 1505-1509
15. Duda S H., Bosiers M, Lammer J et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 2005 16 331-338
16. Scheinert D, Scheinert S, Sax J et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005 45 312-315
17. Schillinger M, Sabeti S, Loewe C et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006 354 1879-1888
18. Katzen B. Veith Symposium; November 23, 2008. New York. Update and new findings from the resilient trial comparing the life stent with POBA: improvement with stenting is durable beyond one year Available at: http://www.medicalnewstoday.com/articles/130504.php
19. Laird J, Jaff M R., Biamino G et al. Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective, multicenter registry. J Vasc Interv Radiol 2005 16 1067-1073
20. Saxon R R., Coffman J M., Gooding J M., Ponec D J. Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions. J Vasc Interv Radiol 2007 18 1341-1349 quiz 1350
21. Saxon R R., Dake M D., Volgelzang R L., Katzen B T., Becker G J. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol 2008 19 823-832
22. Tepe G, Zeller T, Albrecht T et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008 358 689-699
23. Bosiers M. Melopee study 12 months results. International Symposium on Endovascular therapy (ISET) Conference January 22, 2008 Hollywood, FL
24. Idelchik G M., Dougherty K G., Hernandez E, Mortazavi A, Strickman N E., Krajcer Z. Endovascular exclusion of popliteal artery aneurysms with stent-grafts: a prospective single-center experience. J Endovasc Ther 2009 16 215-223
25. Fowkes F G., Housley E, Cawood E H., Macintyre C C., Ruckley C V., Prescott R J. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991 20 384-392
26. Selvin E, Marinopoulos S, Berkenblit G et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004 141 421-431
27. O'Hare A M., Vittinghoff E, Hsia J, Shlipak M G. Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS). J Am Soc Nephrol 2004 15 1046-1051